checkAd

     137  0 Kommentare Aspira Women’s Health to Host R&D Day With Updates on the Development of the Company's Ovarian Cancer and Endometriosis Tests on January 4, 2024 - Seite 3

    Investor Relations Contact:
    Jamie Sullivan
    Director of Corporate Communications
    Aspira Women’s Health
    Jsullivan@aspirawh.com 


    Lesen Sie auch


    globenewswire
    0 Follower
    Autor folgen
    RSS-Feed abonnieren

    Weitere Artikel des Autors

    Seite 3 von 3

    Verfasst von globenewswire
    1 im Artikel enthaltener WertIm Artikel enthaltene Werte
    Aspira Women’s Health to Host R&D Day With Updates on the Development of the Company's Ovarian Cancer and Endometriosis Tests on January 4, 2024 - Seite 3 AUSTIN, Texas, Dec. 19, 2023 (GLOBE NEWSWIRE) - Aspira Women’s Health Inc. (“Aspira” or “the Company”) (Nasdaq: AWH), a bio-analytical based women’s health company focused on the development of gynecologic disease diagnostic tools, today announced …

    Auch bei Lesern beliebt

    Schreibe Deinen Kommentar

    Disclaimer